| Reviews |
 |
|
|
|
|
Reviews to:
Date: Friday, 01. January 2016
Author: Gast
Review:
Have you got any ? dapoxetine price egypt Data supporting the FDA\'s approval of BI\'s new oncology drug included a clinical trial of 345 patients that showed a progression-free survival rate of 4.2 months longer than patients who received chemotherapy, although there was no statistical difference when it came down to overall survival rates.
Evaluation:  |
|
|
|
| Shopping Cart |
 |
|
| You do not have any products in your shopping cart yet. |
|
|
Customer group:Guest
|
|
|
|
